Showing results (711-720 of 999) with videos related to

Sort By:
Pageof 100
Plos One|February 9, 2018
Evaluation of inner retinal layers as biomarkers in mild cognitive impairment to moderate Alzheimer's diseaseEleonora M Lad, Dibyendu Mukherjee, Sandra S Stinnett, et al.
The ISME Journal|September 11, 2021
Transitional genomes and nutritional role reversals identified for dual symbionts of adelgids (Aphidoidea: Adelgidae)Dustin T Dial, Kathryn M Weglarz, Akintunde O Aremu, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|November 23, 2019
Correlation of OCTA and Volumetric MRI in Mild Cognitive Impairment and Alzheimer's DiseaseStephen P Yoon, Atalie C Thompson, Bryce W Polascik, et al.
World Journal for Pediatric & Congenital Heart Surgery|January 5, 2022
Is Porcine Small Intestinal Submucosal Extracellular Matrix (ECM) a Suitable Material for Right Ventricular Outflow Tract Reconstruction in Association With Pulmonary Valve Replacement?Christopher R Burke, Erik Lewis, Nicholas A Schreiter, et al.
Neuropsychologia|September 13, 2005
Emotional enhancement of perceptual priming is preserved in aging and early-stage Alzheimer's diseaseKevin S LaBar, Dana C Torpey, Craig A Cook, et al.
Neuropeptides|April 1, 1985
Increased affinity of dimeric enkephalins is not dependent on receptor densityR A Lutz, T Costa, R A Cruciani, et al.
Molecular Cell|July 6, 2011
Caspase-2-mediated cleavage of Mdm2 creates a p53-induced positive feedback loopTrudy G Oliver, Etienne Meylan, Gregory P Chang, et al.
Nephrology (Carlton, Vic.)|January 25, 2005
Efficacy and side-effect profile of sevelamer hydrochloride used in combination with conventional phosphate bindersJoanna M Sturtevant, Carmel M Hawley, Kylie Reiger, et al.
Nature Communications|October 25, 2017
Harnessing a catalytic lysine residue for the one-step preparation of homogeneous antibody-drug conjugatesAlex R Nanna, Xiuling Li, Even Walseng, et al.
Nucleic Acids Research|July 3, 2016
Selectivity for strand-transfer over 3'-processing and susceptibility to clinical resistance of HIV-1 integrase inhibitors are driven by key enzyme-DNA interactions in the active siteMathieu Métifiot, Barry C Johnson, Evgeny Kiselev, et al.
Pageof 100